Related Experiment Video
Updated: Jun 20, 2026
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Ribonucleases and immunoRNases as anticancer drugs
S M Rybak1, M A E Arndt, T Schirrmann
1Bionanomics, LLC, 411 Walnut Street, Green Cove Springs, FL 32043, USA. rybak@mindspring.com
Current Pharmaceutical Design
|August 20, 2009
Summary
Ribonucleases are emerging drug targets for cancer therapy. Researchers are developing immunoRNases, combining ribonucleases with antibodies, to specifically destroy tumor cells, offering a promising alternative to traditional immunotoxins.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ribonucleases (RNases) are enzymes that degrade RNA.
- RNases are increasingly recognized as important drug targets, particularly in cancer therapy.
- The RNase superfamily includes enzymes like bovine pancreatic RNase A, angiogenin, and ONCONASE, each with distinct properties.
Purpose of the Study:
- To explore the potential of RNases as therapeutic agents for cancer treatment.
- To describe the development and properties of immunoRNases, a novel class of cancer therapeutics.
- To compare the efficacy and construction of immunoRNases with traditional immunotoxins.
Main Methods:
- Characterization of RNase superfamily members, including bovine pancreatic RNase A, angiogenin, and ONCONASE.
- Generation of immunoRNases through chemical conjugation and recombinant fusion protein strategies.
- Evaluation of RNase properties and their application as antibody payloads.
Main Results:
- RNase-based therapeutics, specifically immunoRNases, have demonstrated efficacy in killing tumor cells both in vitro and in vivo.
- ONCONASE has progressed to a Phase IIIb clinical trial for malignant mesothelioma.
- ImmunoRNases offer a sophisticated approach to targeted cancer therapy.
Conclusions:
- RNases represent a viable and potent class of therapeutic agents for cancer treatment.
- ImmunoRNases provide a targeted delivery mechanism for cytotoxic RNases to cancer cells.
- RNase-based strategies offer potential advantages over traditional immunotoxins in cancer therapy.
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:47Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...